Skip to main content

AstraZeneca PLC

AZN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000901832

In the last 90 days, AstraZeneca PLC insiders filed 1 open-market purchase and 0 sales; 1,517 institutions reported holding it in 13F filings for Q2 2026, worth $151.3B in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysLast 90 days, $3.25K in total
1
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +144 vs. previous quarter
1,517
13F valueReported value at the end of Q2 2026
$151.3B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$58.7B
+8.6% year over year
Net income, FY2025
$10.2B
+45.3% year over year
Free cash flow, FY2025
$11.8B
+18.4% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 15, 2026.

Short interest
3.28M
Shares sold short
Change
+665.3K
+25.4% vs. previous
Days to cover
1.11
At average daily volume

Superinvestors holding AZN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding AZN at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by AstraZeneca PLC insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2026 (view filing)4:05 PM ETAug 834 daysLateSharma ManiSee RemarksPPurchase+20.23$160.57+$3.25K+0.1%19.3K after
May 22, 2026 (view filing)May 202 daysSharma ManiSee RemarksSSale−11.9K$185.78−$2.21M−38.2%19.3K after

Top 10 13F holders, Q2 2026

See all 1,517 holders

The largest institutional positions in AstraZeneca PLC at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding AZN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Investor AB51,587,810$9.78B67.92%00.0%Unchanged
Vanguard Capital Management LLC45,386,190$8.47B0.18%+346,048+0.8%Added
Capital International Investors34,576,070$6.49B1.34%+183,057+0.5%Added
Norges Bank33,864,172$6.33B0.63%+33,864,172New
Capital World Investors30,075,134$5.63B0.66%+1,810,554+6.4%Added
FMR LLC28,895,264$5.42B0.24%−706,460−2.4%Reduced
Wellington Management Group LLP28,537,243$5.36B0.92%+4,786,158+20.2%Added
Legal & General Group Plc25,750,245$4.82B1.00%−99,733−0.4%Reduced
JPMorgan Chase & Co19,204,823$3.67B0.21%+613,901+3.3%Added
Vanguard Asset Management, Ltd18,712,920$3.49B2.36%+177,605+1.0%Added

Holders of 5% or more of AZN

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of AstraZeneca PLC.

Largest holders of AZN from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A7.60%117.8M shares–Apr 23, 20251 filingApr 23, 2025SEC
Vanguard Capital Management LLC13G5.02%78.0M sharesNewApr 28, 20261 filingApr 28, 2026SEC

13 members of Congress reported 27 trades in AstraZeneca PLC since 2020. Newest filings:

  1. Alan Armstrong

    Senate · OK · Jul 21, 2026

    Buy$15K-$50K

  2. Alan Armstrong

    Senate · OK · Jul 21, 2026

    Buy$1K-$15K

  3. Julia Letlow

    House · LA · Jan 13, 2026

    Buy$1K-$15K

  4. Gilbert Ray Cisneros, Jr.

    House · CA · Jan 12, 2026

    Buy$1K-$15K

  5. Gilbert Ray Cisneros, Jr.

    House · CA · Dec 15, 2025

    Buy$1K-$15K